Vor Biopharma VOR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 17.84 | 16.01 | -5.11 | -35,160 | -220 | |
| 2025Q4 | 13.08 | -2.09 | 307.61 | -35,960 | 1,723 | |
| 2025Q3 | 48.72 | 3.46 | -121.31 | -28,107 | -813 | |
| 2025Q2 | 32.4 | -251.59 | -274,284 | -1,574 | ||
| 2025Q1 | 14.35 | 102.48 | -5.21 | -33,291 | -32 | |
| 2024Q4 | 22.2 | 101.95 | -8.78 | -31,311 | -31 | |
| 2024Q3 | 14 | 103.46 | -8.05 | -28,513 | -28 | |
| 2024Q2 | 20 | 104.3 | -8.2 | -29,035 | -28 | |
| 2024Q1 | 47.4 | 104.94 | -9 | -32,326 | -31 | |
| 2023Q4 | 45 | 107.09 | -7.6 | -28,124 | -26 | |
| 2023Q3 | 42.4 | 106.41 | -9.8 | -35,316 | -33 | |
| 2023Q2 | 61.8 | 107.32 | -9 | -32,174 | -30 | |
| 2023Q1 | 107.6 | 107 | -8.6 | -30,422 | -28 | |
| 2022Q4 | 133 | 103.41 | -10.4 | -24,725 | -24 | |
| 2022Q3 | 79.6 | 101.32 | -12.4 | -24,101 | -24 | |
| 2022Q2 | 99.4 | 100.61 | -11.6 | -21,792 | -22 | |
| 2022Q1 | 120.8 | 100.28 | -12.2 | -22,800 | -23 | |
| 2021Q4 | 232.4 | 100.3 | -9.6 | -18,306 | -18 | |
| 2021Q3 | 313.6 | 100.26 | -9.8 | -18,602 | -19 | |
| 2021Q2 | 373 | 100.05 | -9.2 | -18,380 | -18 |